Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication
KM Thompson, DA Kalkowska - Expert Review of Vaccines, 2020 - Taylor & Francis
Introduction Over the last 20 years (2000-2019) the partners of the Global Polio Eradication
Initiative (GPEI) invested in the development and application of mathematical models of …
Initiative (GPEI) invested in the development and application of mathematical models of …
Measuring sex, gender, and sexual orientation: one step to health equity
Identity, and Sexual Orientation, 2 was requested by the National Institutes of Health (NIH) in
the USA to examine SOGISC measurement for surveys in research, administrative, and …
the USA to examine SOGISC measurement for surveys in research, administrative, and …
Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine
Although there have been no cases of serotype 2 wild poliovirus for more than 20 years,
transmission of serotype 2 vaccine-derived poliovirus (VDPV2) and associated paralytic …
transmission of serotype 2 vaccine-derived poliovirus (VDPV2) and associated paralytic …
Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use
M Hill, AS Bandyopadhyay, AJ Pollard - The Lancet, 2022 - thelancet.com
Comment 714 www. thelancet. com Vol 400 September 3, 2022 risk of vaccine-associated
paralytic poliomyelitis caused by Sabin 2. 6 Although most countries eliminated Sabinlike …
paralytic poliomyelitis caused by Sabin 2. 6 Although most countries eliminated Sabinlike …
Development of a new oral poliovirus vaccine for the eradication end game using codon deoptimization
JL Konopka-Anstadt, R Campagnoli, A Vincent, J Shaw… - npj Vaccines, 2020 - nature.com
Enormous progress has been made in global efforts to eradicate poliovirus, using live-
attenuated Sabin oral poliovirus vaccine (OPV). However, as the incidence of disease due to …
attenuated Sabin oral poliovirus vaccine (OPV). However, as the incidence of disease due to …
[PDF][PDF] Engineering the live-attenuated polio vaccine to prevent reversion to virulence
The live-attenuated oral poliovirus vaccine (OPV or Sabin vaccine) replicates in gut-
associated tissues, eliciting mucosa and systemic immunity. OPV protects from disease and …
associated tissues, eliciting mucosa and systemic immunity. OPV protects from disease and …
Updated characterization of outbreak response strategies for 2019–2029: impacts of using a novel type 2 oral poliovirus vaccine strain
DA Kalkowska, MA Pallansch, A Wilkinson… - Risk …, 2021 - Wiley Online Library
Delays in achieving the global eradication of wild poliovirus transmission continue to
postpone subsequent cessation of all oral poliovirus vaccine (OPV) use. Countries must stop …
postpone subsequent cessation of all oral poliovirus vaccine (OPV) use. Countries must stop …
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two …
R Wahid, LD Mercer, T De Leon, R DeAntonio… - The Lancet …, 2022 - thelancet.com
Background Sabin strains used in oral poliovirus vaccines (OPV) can revert to virulence and,
in rare instances, cause disease or generate vaccine-derived strains leading to outbreaks in …
in rare instances, cause disease or generate vaccine-derived strains leading to outbreaks in …
Environmental surveillance for poliovirus and other enteroviruses: long-term experience in Moscow, Russian Federation, 2004–2017
OE Ivanova, MS Yarmolskaya, TP Eremeeva… - Viruses, 2019 - mdpi.com
Polio and enterovirus surveillance may include a number of approaches, including
incidence-based observation, a sentinel physician system, environmental monitoring and …
incidence-based observation, a sentinel physician system, environmental monitoring and …
[HTML][HTML] Spherical nucleic acids-based nanoplatforms for tumor precision medicine and immunotherapy
S Liu, CY Yu, H Wei - Materials Today Bio, 2023 - Elsevier
Precise diagnosis and treatment of tumors currently still face considerable challenges due to
the development of highly degreed heterogeneity in the dynamic evolution of tumors. With …
the development of highly degreed heterogeneity in the dynamic evolution of tumors. With …